Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study.
from Latest Science News -- ScienceDaily https://ift.tt/3mH6WSQ
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment